Genentech will invest approximately $750 million to double its Hillsboro, Oregon manufacturing campus with a new device fill-finish facility, adding 250 jobs as the company deepens its two-decade presence in the state amid a broader industry shift toward domestic drug production. Genentech is pouring $750 million into doubling the size of its Hillsboro, Oregon manufacturing […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
Trellis West, a 214,152 SF Hillsboro campus anchored by Applied Materials and...
ByThe RegistryOctober 2, 2026Denver-based Crusoe has signed for an additional 46,475 square feet at Kilroy...
ByThe RegistryOctober 2, 2026The 244-unit transit-oriented building half a block from Roosevelt Station arrives as...
ByThe RegistryOctober 2, 2026Seattle/Puget Sound office leasing slowed to 1.3 million square feet in the...
ByThe RegistryOctober 2, 2026